Ser162
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser162  -  CDK18 iso3 (human)

Site Information
SRMSRRAsLSDIGFG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 468386

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Relevant cell line - cell type - tissue:

References 

1

Possemato A (2009) CST Curation Set: 7394; Year: 2009; Biosample/Treatment: cell line, NCI-H3255/-; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST]
Curated Info

2

Possemato A (2009) CST Curation Set: 7389; Year: 2009; Biosample/Treatment: cell line, HepG2/-; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST]
Curated Info